Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection
- 30 January 2011
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 31 (4), 507-515
- https://doi.org/10.1111/j.1478-3231.2011.02453.x
Abstract
BACKGROUND AND AIMS: Steatosis and insulin resistance (IR) are the major disease modifying in patients with chronic hepatitis C (CHC). Only few studies evaluated these features in patients with chronic hepatitis B (CHB). We aimed to assess the prevalence and the factors related to steatosis and IR in CHB patients, compared with CHC subjects, and to evaluate the potential association between these features and fibrosis severity.\ud \ud MATERIAL AND METHODS: One hundred and seventy consecutive patients with CHB (28 HBeAg positive, 142 HBeAg negative), were evaluated using liver biopsy and metabolic measurements and matched for sex, age and body mass index with 170 genotype 1 CHC patients. IR was defined if HOMA-IR>2.7. All biopsies were scored for grading and staging by Scheuer's score, and the steatosis was considered significant if ≥ 10%.\ud \ud RESULTS: The prevalence of significant steatosis was similar in both CHB and CHC patients (31 vs. 38%; P=0.14). IR rate was significantly higher in CHC than in CHB patients (42 vs. 26%; P=0.002). Severe fibrosis (F3-F4), at multivariate analysis, was independently associated with older age (OR 1.050, 95% CI 1.009-1.093), steatosis >10% (OR 4.375, 95% CI 1.749-10.943), and moderate-severe necroinflammatory activity (OR 8.187, 95% CI 2.103-31.875), regardless of HBeAg status, in CHB patients, and with older age (OR 1.080, 95% CI 1.028-1.136), IR (OR 2.640, 95% CI 1.110-6.281), steatosis >10% (OR 3.375, 95% CI 1.394-8.171), and moderate-severe necroinflammatory activity (OR 8.988, 95% CI 1.853-43.593) in CHC patients.\ud \ud CONCLUSIONS: CHB patients had high steatosis prevalence, similar to CHC controls, but lower IR rate. Both steatosis and IR in CHC, and only steatosis in CHB, are independently associated with fibrosis severityKeywords
This publication has 48 references indexed in Scilit:
- Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the futureJournal of Hepatology, 2009
- Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosisHepatology, 2008
- Insulin Resistance and Diabetes Increase Fibrosis in the Liver of Patients With Genotype 1 HCV InfectionThe American Journal of Gastroenterology, 2008
- Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis CHepatology, 2005
- Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patientsGastroenterology, 2005
- Viral and host causes of fatty liver in chronic hepatitis BWorld Journal of Gastroenterology, 2005
- Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeThe American Journal of Gastroenterology, 2003
- Host- and disease-specific factors affecting steatosis in chronic hepatitis CJournal of Hepatology, 1998
- Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitisGastroenterology, 1993
- Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis BGastroenterology, 1993